ANI Pharma (ANIP) Reports Q3 Loss of $0.37/sh

ANI Pharma (NASDAQ: ANIP) reported Q3 EPS of ($0.37), versus $0.04 reported last year. Revenue for the quarter came in at $52.1 million, versus $52.98 million reported last year.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• Phinia to acquire stoba Group in deal expected to close in Q4 2026